Table 5.
Malaria treatment practices using Malact@ (Artesunate and Amodiquine)
| |
Experimental group |
Control group |
||||||
|---|---|---|---|---|---|---|---|---|
| Pre-interventionn = 200 (%) | Post-interventionn = 190 (%) | Degree of change (%) | Pvalue | Pre-interventionn = 200 (%) | Post-interventionn = 180 (%) | Degree of change (%) | Pvalue | |
|
Malact@ efficacy | ||||||||
| Efficient |
195 (97.5) |
190 (100.0) |
2.5 |
0.28 |
194 (97.0) |
176 (97.7) |
−0.7 |
0.64 |
| Not efficient |
5 (2.5) |
0 (0.0) |
-2.5 |
|
6 (3.0) |
4 (2.3) |
0.7 |
|
|
Malact@ Dose | ||||||||
| Correct |
36 [18.0] |
140 [73.7] |
55.7% |
<0.001 |
45 [22.5] |
40 [22.2] |
−0.3% |
0.78 |
| Over dose |
92 [46.0] |
32 [16.8] |
29.2% |
|
86 [43.0] |
72 [40.0] |
− 3.0% |
|
| Under dose |
72 [36.0] |
18 [9.5] |
26.5% |
|
69 [34.5] |
68 [37.8] |
3.2% |
|
|
Treatment duration (days) | ||||||||
| 1 |
17 (8.5) |
0 (0.0) |
−8.5 |
<0.001 |
11 (5.5) |
10 (5.5) |
0.0 |
0.79 |
| 2 |
26 (13.0) |
27 (14.2) |
0.9 |
|
49 (24.5) |
46 (25.6) |
0.9 |
|
| > 3 |
120 (60.0) |
159 (83.7) |
23.9 |
|
132 (66.0) |
113 (62.8) |
-3.2 |
|
| 3 |
37 (18.5) |
4 (2.1) |
-16.3 |
|
8 (4.0) |
11 (7.1) |
3.1 |
|
|
Commence treatment after symptom recognition | ||||||||
| First day |
146 (73.0) |
185 (97.4) |
24.4 |
<0.001 |
101 (50.5) |
88 (48.9) |
−1.6 |
0.64 |
| Second day |
47 (23.5) |
5 (2.6) |
-20.9 |
|
72 (36.0) |
72 (40.0) |
4.4 |
|
| Third day | 7 (3.5) | 0 (0.0) | -3.5 | 27 (13.5) | 20 (11.1) | -2.6 | ||